OrthoLogic gets bone growth premarket approval (PMA) supplement:
This article was originally published in Clinica
The US FDA has approved a PMA supplement for OrthoLogic's bone growth stimulator. The supplement covers long-term follow-up data which show that the benefits of treatment with the OrthoLogic 1000 bone growth stimulator are sustained at two years. "The data show we are really curing the patients. It gives the clinical study credibility," Orthologic's president and CEO, Dr Allen Weinstein, told Clinica.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.